$MRK

Merck & Co., Inc.

CIK:0000310158|SEC Filings
v3.25.3
CONDENSED CONSOLIDATED STATEMENT OF INCOME - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Income Statement [Abstract]        
Sales $ 17,276 $ 16,657 $ 48,611 $ 48,544
Costs, Expenses and Other        
Cost of sales 3,855 4,080 10,831 11,365
Selling, general and administrative 2,633 2,731 7,835 7,952
Research and development 4,234 5,862 11,903 13,354
Restructuring costs 47 56 676 258
Other (income) expense, net (238) (162) (281) (151)
Total Costs, Expenses and Other 10,531 12,567 30,964 32,778
Income Before Taxes 6,745 4,090 17,647 15,766
Taxes on Income 958 929 2,346 2,377
Net Income 5,787 3,161 15,301 13,389
Less: Net Income Attributable to Noncontrolling Interests 2 4 10 15
Net Income Attributable to Merck & Co., Inc. $ 5,785 $ 3,157 $ 15,291 $ 13,374
Basic Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share) $ 2.32 $ 1.25 $ 6.09 $ 5.28
Earnings per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share) $ 2.32 $ 1.24 $ 6.08 $ 5.26